Classifications within molecular subtypes enables identification of BRCA1/BRCA2 mutation carriers by RNA tumor profiling.
Pathogenic germline mutations in BRCA1 or BRCA2 are detected in less than one third of families with a strong history of breast cancer. It is therefore expected that mutations still remain undetected by currently used screening methods. In addition, a growing number of BRCA1/2 sequence variants of u...
Guardado en:
Autores principales: | Martin J Larsen, Torben A Kruse, Qihua Tan, Anne-Vibeke Lænkholm, Martin Bak, Anne E Lykkesfeldt, Kristina P Sørensen, Thomas V O Hansen, Bent Ejlertsen, Anne-Marie Gerdes, Mads Thomassen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4ccdc704eb1c4c9e9250ec9c36bbdad8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Kara N. Maxwell, et al.
Publicado: (2017) -
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
por: Juliette Coignard, et al.
Publicado: (2021) -
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
por: Juliette Coignard, et al.
Publicado: (2021) -
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ
por: Lina Ding, et al.
Publicado: (2019) -
Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
por: Supriya Behl, et al.
Publicado: (2020)